Genecis Bioindustries
PrivateLast Round
Series A
Extension
Mar 1, 2023
Est. Valuation
$2.14M
Total Funding Raised
$14.83M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genecis Bioindustries is a biotechnology company that converts organic waste into high-performance, biodegradable polyhydroxyalkanoate (PHA) bioplastics.
Sector
Energy & Sustainability
Verticals
Sustainable Materials, Biotechnology, Circular Economy, Clean Manufacturing, Waste Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genecis Bioindustries Comparables
Compare Genecis Bioindustries with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TerraVerdae Bioworks | 86% | |
| Mango Materials | 85% | |
| Dionymer | 85% |
Genecis Bioindustries Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 1, 2023 | ||||
| Debt | Aug 4, 2022 | ||||
| Series A | Aug 4, 2022 | ||||
| Grant | Jul 27, 2021 | ||||
| Accelerator | Mar 1, 2020 | ||||
Grant | Jan 2, 2020 |
Genecis Bioindustries Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IT-Farm Corporation | Series A |
| Khosla Ventures | Series A Extension, Series A |
| Business Development Bank of Canada (BDC Capital) | Series A Extension |
| Re:food | Series A |
| Emerald Technology Ventures | Series A Extension |
| BDC Capital | Series A, Series A Extension |
| Government of Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 219% MoM, reaching 2.4K.
- Jun 20, 2026
Monthly visitors increased 391% MoM.
Recent news
Latest coverage and updates
- partners_withJul 19, 2026
Genecis partners with Helian Polymers BV.
Genecis Bioindustries Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genecis Bioindustries's valuation, stock price, and market status.
Is Genecis a public or private company?
Genecis is a private company.
What is the current stock price of Genecis?
Genecis is a private company with no public stock price. No recent secondary market data is available.
How much is Genecis worth (valuation)?
Genecis's valuation is estimated at $1.8M based on funding round data.
Can I buy Genecis stock?
Genecis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genecis's last funding round?
Genecis's most recent funding round was Series A Extension on March 16, 2020.
Who are the main investors in Genecis?
Key investors in Genecis include Khosla Ventures, BDC Capital, Government of Canada, Y Combinator, Next Generation Manufacturing Canada (NGen).
Will Genecis IPO soon?
No public IPO plans have been announced for Genecis.
How can I track Genecis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genecis's secondary market activity and sign up for updates.